Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.


In spite of its significant morbidity, dysthymic disorder has been under-researched, therefore effective treatment options are limited. This article presents data suggesting that dysthymia can be treated effectively with psychopharmacologic agents. A double-blind, placebo-controlled 7-week drug trial comparing imipramine to ritanserin, a serontonin-2… (More)


  • Presentations referencing similar topics